文献速递颈动脉与弓上血管

连续血糖监测或可检测颈动脉支架置入术中的颈动脉闭塞不耐受

Continuous Blood Glucose Monitoring May Detect Carotid Occlusion Intolerance during Carotid Artery Stenting.
PubMed 文献 · Ann Vasc Surg · 2018-02-05

本研究前瞻性纳入40例择期颈动脉支架置入术(CAS)患者,术中使用人工胰腺以每分钟1次频率连续监测血糖。34例可评估患者中3例(9%)出现颈动脉闭塞不耐受,发生者术中血糖中位数5 mg/dL高于未发生者的0 mg/dL(P=0.0221);血糖升高≥4 mg/dL检测颈动脉闭塞不耐受的敏感度50%、特异度100%。作者认为血糖升高可能有助于检测颈动脉闭塞不耐受,但能否检测脑过度灌注综合征(CHS)仍未知。

要点

  • CAS术中连续血糖监测可行,34例可评估患者中3例(9%)发生颈动脉闭塞不耐受。
  • 发生颈动脉闭塞不耐受者术中血糖中位数5 mg/dL,高于未发生者的0 mg/dL(P=0.0221)。
  • 血糖升高≥4 mg/dL检测颈动脉闭塞不耐受的敏感度50%、特异度100%。

核心结论

  • 血糖升高可能有助于检测颈动脉闭塞不耐受,但血糖监测能否检测脑过度灌注综合征(CHS)仍未知。
  • 作者建议进一步研究验证CAS术中血糖升高≥4 mg/dL可提示颈动脉闭塞不耐受。

研究设计与样本

  • 前瞻性纳入40例择期颈动脉支架置入术(CAS)患者。
  • 术中使用人工胰腺连续监测血糖(每分钟1次),以2 mL/hr速率抽取静脉血。
  • 主要终点为血糖变化与不良事件的相关性。

主要发现

  • 1例患者中止CAS,5例患者(12.5%)因无法抽血而未测血糖。
  • 34例可评估患者中无患者发生脑过度灌注综合征(CHS),3例(9%)发生颈动脉闭塞不耐受。
  • CAS术中发生颈动脉闭塞不耐受者血糖中位数5 mg/dL,高于未发生者的0 mg/dL(P=0.0221)。
  • CAS术中血糖升高≥4 mg/dL检测颈动脉闭塞不耐受的敏感度50%、特异度100%。
  • 血糖变化与其他不良事件无显著相关性。

关键数值与推荐

  • CAS术中血糖升高≥4 mg/dL检测颈动脉闭塞不耐受的敏感度50%、特异度100%。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 1例患者中止CAS,5例患者(12.5%)因无法抽血而未测血糖。
  • 血糖监测能否检测脑过度灌注综合征(CHS)仍未知。
  • 作者指出需进一步研究验证CAS术中血糖升高≥4 mg/dL可提示颈动脉闭塞不耐受。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The frequency of the occurrence of adverse events associated with carotid artery stenting (CAS) is usually low, but serious adverse events such as cerebral hyperperfusion syndrome (CHS) may occur. Real-time monitoring is ideal for the early detection of adverse events during the surgical procedure. This study aimed to evaluate continuous blood glucose (BG) monitoring for the detection of adverse events during CAS. METHODS: Forty patients undergoing scheduled CAS were prospectively enrolled. An artificial pancreas was used for continuous BG monitoring (once per minute), using venous blood extracted at a rate of 2 mL/hr during CAS. The primary endpoint was a correlation between BG change and adverse events. RESULTS: CAS was discontinued in 1 patient, and BG was not measured in 5 patients (12.5%) because of the inability to extract blood. Among 34 evaluable patients, no patient developed CHS, but 3 patients (9%) experienced carotid occlusion intolerance. During CAS, BG was significantly higher in patients with carotid occlusion intolerance (median: 5 mg/dL) than in patients without carotid occlusion intolerance (median: 0 mg/dL) (P = 0.0221). A cutoff BG value ≥4 mg/dL during CAS showed 50% sensitivity and 100% specificity for the detection of carotid occlusion intolerance. There was no significant correlation between BG change and other adverse events. CONCLUSIONS: BG elevation may help detect carotid occlusion intolerance although it is still unknown whether BG monitoring can detect CHS. Further studies should validate that a cutoff BG elevation value of ≥4 mg/dL during CAS indicates carotid occlusion intolerance.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Hiramatsu R, Furuse M, Yagi R, et al. Continuous Blood Glucose Monitoring May Detect Carotid Occlusion Intolerance during Carotid Artery Stenting. Ann Vasc Surg. 2018. PMID: 29421420. doi:10.1016/j.avsg.2017.10.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。